Last reviewed · How we verify
Miracle Fruit
At a glance
| Generic name | Miracle Fruit |
|---|---|
| Also known as | supportive care |
| Sponsor | Mt. Sinai Medical Center, Miami |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Pilot Study of Freeze-Dried Miracle Fruit (MiraBurst) on Participants Receiving Cancer Treatment (NA)
- A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS) (NA)
- Addressing Taste Dysfunction With Miraculin in Head and Neck Cancer Patients Receiving Radiation Therapy (PHASE3)
- Effects of Miracle Fruit Pill Application on Food Likings and Energy Intake in Diabetic or Prediabetic Patients (NA)
- Miracle Fruit Powder for the Treatment of Taste Alterations Secondary to Chemotherapy (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Miracle Fruit CI brief — competitive landscape report
- Miracle Fruit updates RSS · CI watch RSS
- Mt. Sinai Medical Center, Miami portfolio CI